SCHEMBL5279447

SCHEMBL5279447

C=CCc1ccc(OC)c2c(=O)c3cccc(OC)c3oc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 10/20 0.48
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
LMNA P02545 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ELANE P08246 1/20 0.42
HPGD P15428 3/20 0.41
ABCG2 Q9UNQ0 1/20 0.39
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MGAM O43451 1/20 0.38
ESR1 P03372 1/20 0.38
KDM5A P29375 1/20 0.38
ESR2 Q92731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5457380 0.76 MAOA (0.48) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL6281277 0.72 LOXL2 (0.44) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL7958885 0.71 ALDH1A1 (0.45) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL7236286 0.71 MAOA (0.68) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL6285040 0.70 MAOA (0.72) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL4039513 0.69 ABCG2 (0.46) MAOAALDH1A1KDM4ELMNAELANE
SCHEMBL14443973 0.69 IKBKB (0.58) MAOAKDM4ECYP3A4
SCHEMBL14443979 0.69 NUDT1 (0.53) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL20346660 0.69 MAOA (0.62) MAOAALDH1A1KDM4ELMNANPC1
SCHEMBL7948739 0.68 KDM4E (0.41) MAOAALDH1A1KDM4ELMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1585740-A4 PROCESS TO PREPARE PSOROSPERMIN CYLENE PHARMACEUTICALS INC (US) 2007-06-13 EP disclosed
EP-1585740-A2 PROCESS TO PREPARE PSOROSPERMIN Cylene Pharmaceuticals, Inc. (US) 2005-10-19 EP disclosed
US-6933396-B2 Process to prepare psorospermin CYLENE PHARMACEUTICALS (US) 2005-08-23 US disclosed
US-20040102515-A1 Process to prepare psorospermin CYLENE PHARMACEUTICALS 2004-05-27 US disclosed
WO-2004019888-A2 PROCESS TO PREPARE PSOROSPERMIN CYLENE PHARMACEUTICALS, INC. (US) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102515-A1 Process to prepare psorospermin BPGM, DHPS, FDPS MAOA 761/4885ALDH1A1 2689/4885KDM4E 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.